Rapid Antiretroviral Therapy Among Individuals With Acute and Early HIV
- PMID: 32777035
- PMCID: PMC8246801
- DOI: 10.1093/cid/ciaa1174
Rapid Antiretroviral Therapy Among Individuals With Acute and Early HIV
Abstract
HIV transmission is increased during acute and early HIV (AEH). Rapid antiretroviral therapy may shorten the duration of infectivity. We show rapid antiretroviral therapy in AEH is acceptable and effective, with 69.0% of participants starting ART within 7 days of HIV diagnosis disclosure, and 88.1% achieving suppression by 48 weeks.
Keywords: HIV; acute HIV; rapid ART.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Rapid Antiretroviral Therapy: Time for a new Standard of Care.Clin Infect Dis. 2021 Jul 1;73(1):134-136. doi: 10.1093/cid/ciaa1171. Clin Infect Dis. 2021. PMID: 32777033 No abstract available.
References
-
- Centers for Disease Control and Prevention (CDC). HIV continuum of care, U.S., 2014, overall and by age, race/ethnicity, transmission route and sex. Available at: http://www.cdc.gov/nchhstp/newsroom/2017/HIV-Continuum-of-Care.html. Accessed 27 November 2014.
-
- Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687–93. - PubMed
-
- Brenner BG, Roger M, Routy JP, et al. ; Quebec Primary HIV Infection Study Group . High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195:951–9. - PubMed
